» Authors » Luisa F Duarte

Luisa F Duarte

Explore the profile of Luisa F Duarte including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 484
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Duarte L, Carbone-Schellman J, Bueno S, Kalergis A, Riedel C, Gonzalez P
Clin Microbiol Rev . 2025 Feb; 38(1):e0014724. PMID: 39982077
SUMMARYAntivirals play important roles in restricting viral diseases. Nevertheless, they act on a relatively limited number of viruses and occasionally display partial effectiveness in some tissues or against escape variants....
2.
Rosenberger A, Bickeboller H, Christiani D, Liu G, Schabath M, Duarte L, et al.
Cancer Med . 2024 Aug; 13(16):e70126. PMID: 39194344
Background: Radon is a radioactive gas and a major risk factor for lung cancer (LC). Methods: We investigated the dose-response relationship between radon and LC risk in the International Lung...
3.
Duarte L, Villalobos V, Farias M, Rangel-Ramirez M, Gonzalez-Madrid E, Navarro A, et al.
Commun Biol . 2024 Jul; 7(1):811. PMID: 38965360
Experimental autoimmune encephalomyelitis (EAE) is a demyelinating disease affecting the central nervous system (CNS) in animals that parallels several clinical and molecular traits of multiple sclerosis in humans. Herpes simplex...
4.
Reyes A, Ortiz G, Duarte L, Fernandez C, Hernandez-Armengol R, Palacios P, et al.
Front Cell Infect Microbiol . 2023 Sep; 13:1229098. PMID: 37753486
Cellular senescence is a key biological process characterized by irreversible cell cycle arrest. The accumulation of senescent cells creates a pro-inflammatory environment that can negatively affect tissue functions and may...
5.
Duarte L, Vazquez Y, Diethelm-Varela B, Pavez V, Berrios-Rojas R, Mendez C, et al.
J Infect Dis . 2023 Aug; 228(7):857-867. PMID: 37572355
Background: We sought to identify potential antigens for discerning between humoral responses elicited after vaccination with CoronaVac (a severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] inactivated vaccine), natural infection, or...
6.
Tognarelli E, Duarte L, Farias M, Cancino F, Corrales N, Ibanez F, et al.
Antioxidants (Basel) . 2023 Jun; 12(6). PMID: 37371900
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections are highly prevalent in the human population and produce mild to life-threatening diseases. These viruses interfere with the function...
7.
Mendez C, Penaloza H, Schultz B, Pina-Iturbe A, Rios M, Moreno-Tapia D, et al.
EBioMedicine . 2023 Apr; 91:104563. PMID: 37099842
Background: The Omicron variant has challenged the control of the COVID-19 pandemic due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 vaccine showed positive effects...
8.
Duarte L, Gatica S, Castillo A, Kalergis A, Bueno S, Riedel C, et al.
Microbes Infect . 2022 Dec; 25(5):105084. PMID: 36586461
Numerous studies relate the onset and severity of multiple sclerosis (MS) with viral infections. Herpes simplex virus type 1 (HSV-1), which is neurotropic and highly prevalent in the brain of...
9.
Soto J, Melo-Gonzalez F, Gutierrez-Vera C, Schultz B, Berrios-Rojas R, Rivera-Perez D, et al.
mBio . 2022 Nov; 13(6):e0131122. PMID: 36383021
Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated...
10.
Galvez N, Pacheco G, Schultz B, Melo-Gonzalez F, Soto J, Duarte L, et al.
Elife . 2022 Oct; 11. PMID: 36226829
Background: The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine...